| Title of the Event | International Seminar on “Biomedical/BioScience on Hypoxia Signaling Pathways in Cancer and Neurobiology” |
| Date | 30.01.2025 |
| Time | 09.30AM-10.30AM |
| Venue | MBA Conference Hall |
| Total Attendees | 60 |
| Name of the Speaker | Momna Hejmadi, Associate PVC Education, Specializes in Bioscience Education, University of Bath, UK |
| Event Mode | Offline |
| Convenor | Dr Abraham Benjamin Samuel Assistant Director, International Relations |
| Co-Convenor | Dr.Ushus s Kumar, HoD(i/C)/BME |
| Coordinator | Ms.P.Padmapriya, AP/BME |
Summary of the Event
“Biomedical/BioScience on Hypoxia Signaling Pathways in Cancer and Neurobiology” provided an in-depth exploration of the crucial role of hypoxia in cellular function, disease progression, and therapeutic strategies. Experts from the fields of biomedical science and bioscience discussed how oxygen deprivation influences key biological processes in cancer and neurobiology.
The session covered molecular mechanisms of hypoxia, focusing on hypoxia-inducible factors (HIFs) and their role in tumor adaptation, angiogenesis, metabolic reprogramming, and drug resistance. The seminar also highlighted the impact of hypoxia on neurodegenerative diseases, including its effect on neuronal survival, inflammation, and cognitive function.
Speaker emphasized recent advancements in targeting hypoxia signaling for cancer therapy and potential neuroprotective strategies. Case studies and research findings showcased innovative diagnostic and therapeutic approaches, fostering discussions on future biomedical applications.
Conclusion
The Seminar on Hypoxia Signaling Pathways in Cancer and Neurobiology successfully provided a comprehensive understanding of how oxygen deprivation influences cellular mechanisms in both cancer progression and neurodegenerative diseases. Experts and researchers shared valuable insights into the role of hypoxia-inducible factors (HIFs), metabolic adaptations, angiogenesis, and potential therapeutic interventions.
The discussions emphasized the translational significance of hypoxia research, particularly in developing targeted therapies for cancer treatment and exploring neuroprotective strategies for neurodegenerative conditions. The interactive Q&A session facilitated knowledge exchange, encouraging further research collaborations and innovative approaches in biomedical and bioscience domains.
In conclusion, the seminar highlighted the critical importance of hypoxia signaling in disease mechanisms, inspiring participants to explore cutting-edge research and clinical applications. As advancements in this field continue, interdisciplinary efforts will be essential in translating these insights into impactful medical solutions.
